Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Other Operating Expenses (2016)

Historic Other Operating Expenses for vTv Therapeutics (VTVT) over the last 3 years, with Q3 2016 value amounting to $529000.0.

  • vTv Therapeutics' Other Operating Expenses fell 957.26% to $529000.0 in Q3 2016 from the same period last year, while for Jun 2017 it was $529000.0, marking a year-over-year decrease of 6824.73%. This contributed to the annual value of $795000.0 for FY2016, which is 6612.7% down from last year.
  • Per vTv Therapeutics' latest filing, its Other Operating Expenses stood at $529000.0 for Q3 2016, which was down 957.26% from $72000.0 recorded in Q2 2016.
  • In the past 5 years, vTv Therapeutics' Other Operating Expenses ranged from a high of $815000.0 in Q4 2015 and a low of $72000.0 during Q2 2016
  • In the last 3 years, vTv Therapeutics' Other Operating Expenses had a median value of $448000.0 in 2014 and averaged $423100.0.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 17815.7% in 2015, then tumbled by 8705.04% in 2016.
  • vTv Therapeutics' Other Operating Expenses (Quarter) stood at $293000.0 in 2014, then soared by 178.16% to $815000.0 in 2015, then plummeted by 35.09% to $529000.0 in 2016.
  • Its Other Operating Expenses was $529000.0 in Q3 2016, compared to $72000.0 in Q2 2016 and $194000.0 in Q1 2016.